Eikonizo Therapeutics

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of brain-penetrant and peripherally-restricted small molecules designed to slow or modify the progression of neurodegenerative and cardiorenal diseases. Eikonizo Therapeutics is based in Cambridge, MA and was founded in 2017. It was valued at $54 million at its later-stage round in Dec 2023, the last priced event on record. It has raised $46.1 million across 2 recorded rounds; the latest was a $371,352 seed round in May 2018.

PMV mark · valuation
$54.0M
Oct 2026
Priced at
its later-stage round
Dec 2023
Total raised
$46.1M
Last round
Seed Round
May 2018
How much has Eikonizo Therapeutics raised?
$46.1Macross 2 recorded rounds · Mar 2018 – May 2018

Most recently, Eikonizo Therapeutics raised $371K in its Seed Round (May 2018).

Free account
More of Eikonizo Therapeutics with a free account
  • ·Watch Eikonizo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Eikonizo Therapeutics round by round

2 rounds
May 2018Seed Round$371KSEC filing▮
1 investors participated
Mar 2018Seed Round$2.0MSEC filing▮
2 investors participated

How much has Eikonizo Therapeutics raised?

Eikonizo Therapeutics has raised $46.1 million in total; 2 of its rounds are on record. The largest on record was a $371,352 seed round in May 2018.

Eikonizo Therapeutics has filed 2 Form Ds with the SEC, most recently in May 2018 ($371,352 sold to 1 investor).

Eikonizo Therapeutics investors

8 investors are on record for Eikonizo Therapeutics, including National Institutes of Health, F-Prime Capital, Johnson & Johnson Innovation - JLABS and Mission BioCapital. The seed round in May 2018 drew 1 investor.

For fundraisers
Raising for a company like Eikonizo Therapeutics?

8 investors have backed Eikonizo Therapeutics.

See all 8 investors →

Frequently asked about Eikonizo Therapeutics

How much has Eikonizo Therapeutics raised?
Eikonizo Therapeutics has raised $46.1M in total across 2 recorded funding rounds.
When was Eikonizo Therapeutics's last funding round?
Eikonizo Therapeutics's most recent recorded round was Seed Round in May 2018, raising $371K.